ELLODI PHARMACEUTICALS
Live / Registered — Registered (as of 10 Sept 2024)
What this means for you
Registered since 10 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90237966
- Registration number
- 7502595
- Mark type
- Stylized text
- Filed
- 06 Oct 2020
- Published for opposition
- 13 Apr 2021
- Registered
- 10 Sept 2024
- Attorney of record
- Allison Z. Gifford
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, therapeutic, and biological preparations for the treatment and prevention of medical conditions, rare diseases, and disorders in the fields of gastroenterology and hepatology; pharmaceutical, therapeutic, and biological preparations for the treatment and prevention of eosinophilic esophagitis
- Class 042 — Scientific and technological services: Pharmaceutical research, development, and consulting services in the pharmaceutical and biotechnology fields
- Class 044 — Medical, beauty and agricultural services: Providing medical information to health care professionals and patients
Owner
- Ellodi Pharmaceuticals, L.P., Blue Bell, PA, US
- Ellodi Pharmaceuticals, L.P., Blue Bell, PA, US
- Ellodi Pharmaceuticals, L.P., Lawrenceville, NJ, US
Prosecution history
- 10 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 02 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 29 May 2024 — USE AMENDMENT FILED
- 29 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 14 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Dec 2023 — SOU EXTENSION 5 GRANTED
- 01 Dec 2023 — SOU EXTENSION 5 FILED
- 12 Dec 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Dec 2023 — SOU TEAS EXTENSION RECEIVED
- 10 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jun 2023 — SOU EXTENSION 4 GRANTED
- 08 Jun 2023 — SOU EXTENSION 4 FILED